Form 4: Waystar Holding Corp. Executive Christopher L. Schremser Reports Stock and Option Grants

Sentiment:

SEC Form 4 Filing


Christopher L. Schremser, Chief Technology Officer of Waystar Holding Corp., reports the acquisition of restricted stock units and stock options.

Summary

  • Christopher L. Schremser, the Chief Technology Officer of Waystar Holding Corp., filed a Form 4 detailing changes in beneficial ownership.
  • On June 10, 2024, Schremser acquired 173,913 shares of Common Stock through a grant of restricted stock units (RSUs).
  • These RSUs vest in five substantially equal annual installments starting on June 6, 2025.
  • Each RSU represents the right to receive one share of common stock upon settlement.
  • On May 1, 2024, Schremser was granted options to purchase 72,600 shares of Common Stock at an exercise price of $37.2, vesting in three substantially equal annual installments commencing on May 1, 2025.
  • On June 6, 2024, Schremser was granted options to purchase 434,782 shares of Common Stock at an exercise price of $21.5, vesting in five substantially equal annual installments commencing on June 6, 2025.
  • The May 1, 2024 and June 6, 2024 grants were previously reported on a Form 3 filed on June 7, 2024.
  • The May 1, 2024 grant reflects the 0.605-for-1 reverse stock split which became effective on May 15, 2024.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing detailing stock and option grants. It's neutral in tone and reflects routine compensation practices. The sentiment is moderately positive as it indicates continued investment in key personnel.

Positives

  • The grant of RSUs and stock options to the CTO could be seen as an incentive to align his interests with the long-term success of the company.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules of the RSUs and stock options suggest a multi-year commitment from the executive.

Industry Context

Stock option and RSU grants are common compensation practices in the tech industry to attract and retain talent, aligning executive interests with shareholder value.

Comparison to Industry Standards

  • Companies like Veeva Systems and Cerner (now Oracle Health) also utilize stock options and RSU grants as part of their executive compensation packages.
  • The vesting schedules and grant sizes are generally comparable to industry standards for similar-sized companies in the technology sector.

Stakeholder Impact

  • Shareholders may view the grants as a positive sign of incentivizing management.
  • Employees may see the grants as a reflection of the company's commitment to its leadership.

Key Dates

DateDescription
05/01/2024Date of earliest transaction and grant date for stock options to purchase 72,600 shares.
05/15/2024Effective date of the 0.605-for-1 reverse stock split.
06/06/2024Grant date for stock options to purchase 434,782 shares and vesting start date for RSUs.
06/10/2024Date of RSU grant for 173,913 shares.
06/12/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.